Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 21, 2009Personalized MedicineOpen Access

Clinical Trial Designs for Evaluating the Medical Utility of Prognostic and Predictive Biomarkers in Oncology

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRichard Simon

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Richard Simon (2009) studied this question.

synapsesocial.com/papers/69dd45bfac7bdbc6c7101601https://doi.org/10.2217/pme.09.49
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Validation of Analytic Methods for Biomarkers Used in Drug Development2008 · 240 citations
  2. 2Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker2000 · 2,977 citations
  3. 3Critical Review of Published Microarray Studies for Cancer Outcome and Guidelines on Statistical Analysis and Reporting2007 · 632 citations
  4. 4Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification2003 · 1,018 citations
  5. 5Prediction error estimation: a comparison of resampling methods2005 · 1,370 citations